Ningaloo

Booth: 24 - 27

At Ningaloo Biosystems, we are transforming the way advanced drugs are manufactured. Our cutting-edge optogenetic cell modulation systems empower biopharma companies to overcome scalability barriers and drastically reduce the high production costs of next-generation, complex biopharmaceuticals. This innovation is crucial to ensuring that breakthrough therapies for cancer, autoimmune diseases, and genetic disorders become economically viable—making them accessible to millions of patients worldwide.

Discover how we are using biophotonics to kickstart a new era of cyber biotechnology.

Contact

Ningaloo Biosystems

Herbert Mueller-Hartmann

E-Mail: h.mueller-hartmann@ningaloo.bio